The argument
Health systems have the largest buying committees in B2B and the longest silences. Conversation intelligence is weighted high because a named clinical champion is the single best predictor here, and champions reveal themselves on calls rather than on websites. Buying process is close behind: a business associate agreement, a security assessment, or a clinical review is real progress. Long gaps are structural, not fatal, so the going quiet signature is reduced. The committee signature is amplified because a second and third stakeholder appearing is the actual mechanism by which these deals advance, and a deal that never adds a second name almost never closes.
The weights
Published, because a score you cannot audit is a score nobody trusts.
76% of the score comes from what the company does, 24% from what named people do. Within each side, these are the shares.
Company signals
Person signals
See it against a real pipeline.
The demo loads with these weights. Move them and watch the deals reorder.
Past the score.
The same evidence finds accounts: past champions who moved, companies hiring the way your wins did, and companies that look like your wins, with lead routing and agents on top. Every list is checked against your own won and lost deals, so what counts in your industry is what counted for you.
Kaypo for mid-market teamsJob postings that come before a deal
